UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM 973100

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2011-07-15 for UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM 973100 manufactured by Beckman Coulter, Inc..

Event Text Entries

[22128313] The customer reported elevated creatine kinase-mb (ck-mb) results for one patient involving unicel dxi 800 access immunoassay system. This is report number one of six referencing system (b)(4). Two previous samples from the same patient produced normal ck-mb results. A third sample was collected but did not produce ck-mb results. The elevated results were released out of the laboratory. There was no report of patient injury or change in patient treatment associated with this event. The field service engineer (fse) went to the facility and assessed the unit.
Patient Sequence No: 1, Text Type: D, B5


[22257407] The field service engineer (fse) serviced the unit at the facility on (b)(4) 2008. Prior to the event, the fse was at the facility and completed a preventive maintenance (pm). The fse performed and completed system check. The fse performed and completed twenty-replicate precision tests for creatine kinase-mb (ck-mb) and troponin. All results were within expectations and conformed to the manufacturer's established specifications. Quality control (qc) was performed approximately 23 hours prior to the event and resulted within range. A system check completed on (b)(6) 2008 conformed to specifications. The customer stated the five replicate precision test of the patient's sample was performed following the system clean routine. A review of archive data, collected on (b)(6) 2008, showed a daily system cleaning had not been performed. The sample was collected into a bd plasma lithium heparin plastic tube with gel. The customer could not provide specifics details regarding sample collection, only that the sample was likely collected in by the nursing staff and was a full draw. The re-centrifugation of the primary tube occurred in the primary tube and not an aliquot. Re-centrifugation of the primary tube can lead to cellular debris. The assay manual does provide guidelines to ensure residual fibrin and cellular matter have been removed prior to analysis and to follow recommendations for centrifugation of the tube manufacturer. Product labeling: the access ck-mb results should be interpreted in light of the total clinical presentation of the patient, including: symptoms, clinical history, data from additional tests and other appropriate information. This reportable event was identified during a retrospective review of product complaints conducted from (b)(4) 2008 through (b)(4) 2010 for additional reportable events. This medwatch report is related to mdrs: 2122870-2011-02325, 02326, 02327, 02328, 02329.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2122870-2011-02286
MDR Report Key2169764
Report Source05,06
Date Received2011-07-15
Date of Report2008-03-19
Date of Event2008-03-19
Date Mfgr Received2008-03-19
Device Manufacturer Date2008-03-01
Date Added to Maude2011-10-05
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMS NORA ZEROUNIAN
Manufacturer Street250 S. KRAEMER BLVD.
Manufacturer CityBREA CA 92821
Manufacturer CountryUS
Manufacturer Postal92821
Manufacturer Phone7149613634
Manufacturer G1BECKMAN COULTER, INC.
Manufacturer Street1000 LAKE HAZELTINE DR.
Manufacturer CityCHASKA MN 55318
Manufacturer CountryUS
Manufacturer Postal Code55318
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameUNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM
Product CodeJHS
Date Received2011-07-15
Model NumberNA
Catalog Number973100
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerBECKMAN COULTER, INC.
Manufacturer Address1000 LAKE HAZELTINE DR. CHASKA MN 55318 US 55318


Patients

Patient NumberTreatmentOutcomeDate
10 2011-07-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.